As of June 30, 2026, Jolt Health Inc. carries a market capitalization of 827,369.01, placing it among publicly traded companies globally. Its enterprise value stands at 861,026.01, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 827,369.01 |
| Enterprise Value | 861,026.01 |
As of June 30, 2026, Jolt Health Inc. has 12.73M shares outstanding.
| Shares Outstanding | 12.73M |
These figures are as of June 30, 2026.
| PB Ratio | -1.01 |
| P/TBV Ratio | -1.01 |
| P/FCF Ratio | -24.17 |
| P/OCF Ratio | -24.17 |
As of June 30, 2026, Jolt Health Inc. maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.02 |
| Debt / Equity | -4.46 |
| Debt / EBITDA | -0.12 |
These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -480.13, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -480.13 |
As of the close on July 31, 2026, Jolt Health Inc.'s stock has declined approximately 61.11% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.10.
| 52-Week Price Change | -61.11% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.10 |
Over the twelve months ended June 30, 2026, Jolt Health Inc. generated - - in revenue and converted that into -305,288.00 in net income, yielding earnings per share of -0.03. EBITDA reached -311,748.00, while operating income came in at -652,962.00.
| Operating Income | -652,962.00 |
| Pretax Income | -305,288.00 |
| Net Income | -305,288.00 |
| EBITDA | -311,748.00 |
| EBIT | -311,748.00 |
| Earnings Per Share (EPS) | -0.03 |
As of June 30, 2026, Jolt Health Inc. holds 2,997.00 in cash and equivalents against 36,654.00 in total debt, resulting in a net debt position of 33,657.00. Total book value stands at -822,706.00, with working capital of -822,706.00 providing operational flexibility.
| Cash & Cash Equivalents | 2,997.00 |
| Total Debt | 36,654.00 |
| Net Debt | 33,657.00 |
| Equity (Book Value) | -822,706.00 |
| Book Value Per Share | -0.06 |
| Working Capital | -822,706.00 |
Jolt Health Inc. produced -31,210.00 in operating cash flow over the twelve months ended June 30, 2026.
| Operating Cash Flow | -31,210.00 |
| Free Cash Flow | -31,210.00 |
These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -4.14: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -4.13, meaning Jolt Health Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -4.13 |
| FCF Yield | -4.14 |
Jolt Health Inc.'s most recent stock split took place on February 26, 2025 with a 20:1 split ratio.
| Last Split Date | 2/26/2025 |
| Split Ratio | 20:1 |
As of June 30, 2026, Jolt Health Inc. has an Altman Z-Score of -1,457.29, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1,457.29 |
Already premium?